Medicare Agency Sees Role For Itself In Device Postmarket Surveillance
This article was originally published in The Gray Sheet
Executive Summary
CMS indicates it wants to play a more active role in the postmarket surveillance of implanted devices in its fiscal 2008 hospital inpatient 1proposed rule